About
Bruce Booth is a partner at Atlas Venture focused on the discovery and development of novel medicines and therapeutic platforms. He joined Atlas in 2005 after working as a consultant at McKinsey & Company and as an investor for Caxton Health Holdings. He holds a D.Phil. in molecular immunology from Oxford University, which he attended as a British Marshall Scholar, and a BS in biochemistry from The Pennsylvania State University.
Bruce Booth @lifescivc
New blog: "Evolving Drug Discovery: AI, Infrastructure, and the Speed of Learning" Great perspective from @AbbasRKazimi, CEO of Nimbus Therapeutics - a company that's been at the forefront of deploying computational technologies to discover and develop new medicines for almost
Jul 28, 2026 · ♥ 96 · ⇄ 11
Bruce Booth @lifescivc
Great commentary and spot-on from @docrodwong https://t.co/aTChW6xgXR
Jul 27, 2026 · ♥ 35 · ⇄ 1
Bruce Booth @lifescivc
In a new blog "Two Roads Diverged" - Atlas' Aimee Raleigh explores the often "artificial chasm" that has been constructed between biotech operators and VCs... with tips for how to engage in more positive and productive ways. @AimeeRaleigh13 @atlasventure https://t.co/wNtGHuUfBS
Jun 30, 2026 · ♥ 13 · ⇄ 1
Invests in
Biotech
Investments
Board seats
AvilaHotspot TherapeuticsKymera TherapeuticsLifordi ImmunotherapeuticsLysosomal TherapeuticsMatchpoint TherapeuticsNimbus LakshmiPadlock TherapeuticsRodin TherapeuticsSionna TherapeuticsSpolia TherapeuticsStromedixVigil Neuroscience
Investor
Nimbus Therapeutics
Per the firm's website.
Colleagues at Atlas Venture
Network7
Investors connected to Bruce in public investor directories — a warm-intro map.